12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks showed significant movement. Tevogen Bio Holdings led the gainers with an 85.5% increase, while Telesis Bio experienced the largest drop among the losers, falling 11.8%. Other notable movers include Candel Therapeutics and Achilles Therapeutics, with the former rising 27.97% and the latter declining by 10% following its Q4 earnings release.
April 04, 2024 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Achilles Therapeutics stock declined by 10% to $1.08 following its Q4 earnings release, with a market value of $44.0 million.
Achilles Therapeutics' stock price drop post-Q4 earnings suggests the market's reaction may be due to disappointing results or outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 95
NEGATIVE IMPACT
Telesis Bio stock fell 11.8% to $0.42, with a market cap of $12.6 million.
The decline in Telesis Bio's stock price could reflect negative investor sentiment or reactions to recent company developments.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Candel Therapeutics shares rose 27.97% to $2.15, with a market cap of $63.0 million.
Candel Therapeutics' stock price increase suggests positive market sentiment, potentially due to favorable company news or sector trends.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Tevogen Bio Holdings stock rose 85.5% to $4.86, with a market value of $800.0 million.
The significant rise in Tevogen Bio Holdings' stock price indicates strong investor interest, likely due to positive developments or expectations.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100